Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TJX Companies
TJX
|
+$211M |
| 2 |
HOUS
Anywhere Real Estate
HOUS
|
+$145M |
| 3 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
+$132M |
| 4 |
Apple
AAPL
|
+$125M |
| 5 |
Omnicom Group
OMC
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.13B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$725M |
| 3 |
Microsoft
MSFT
|
+$443M |
| 4 |
AGN
Allergan Inc
AGN
|
+$318M |
| 5 |
EOG Resources
EOG
|
+$259M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Financials | 13.48% |
| 3 | Healthcare | 13.02% |
| 4 | Energy | 10.79% |
| 5 | Industrials | 10.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BKYF
3101
DELISTED
BK KY FINL CORP
BKYF
| $1.29M | ﹤0.01% |
36,995
-900
| -2% | -$31.4K |
|
3102
Escalade
ESCA
$288M
| $1.28M | ﹤0.01% |
79,529
+30,229
| +61% | +$459K |
|
|
OSIR
3103
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $1.28M | ﹤0.01% |
82,172
+115
| +0.1% | +$1.69K |
|
|
BCS.PRA.CL
3104
DELISTED
Barclays Bank Plc Series 3
BCS.PRA.CL
| $1.28M | ﹤0.01% |
50,144
| – | – |
|
3105
WisdomTree US SmallCap Dividend Fund
DES
$2.24B
| $1.28M | ﹤0.01% |
54,696
+1,581
| +3% | +$35.8K |
|
3106
Ryanair
RYAAY
$30.6B
| $1.28M | ﹤0.01% |
55,777
-130,265
| -70% | -$2.98M |
|
|
ORBC
3107
DELISTED
ORBCOMM, Inc.
ORBC
| $1.27M | ﹤0.01% |
193,372
+28,989
| +18% | +$184K |
|
3108
ASE Group
ASX
$102B
| $1.27M | ﹤0.01% |
195,525
-60,140
| -24% | -$364K |
|
3109
Pathward Financial
CASH
$1.8B
| $1.27M | ﹤0.01% |
95,370
+714
| +0.8% | +$9.4K |
|
3110
iShares MSCI ACWI ex US ETF
ACWX
$12B
| $1.27M | ﹤0.01% |
26,430
+15,257
| +137% | +$728K |
|
|
PCO
3111
DELISTED
Pendrell Corporation - Class A
PCO
| $1.27M | ﹤0.01% |
721
-8
| -1% | -$13.2K |
|
3112
Bank of Marin Bancorp
BMRC
$464M
| $1.26M | ﹤0.01% |
55,352
+568
| +1% | +$12.6K |
|
3113
VanEck Gold Miners ETF
GDX
$27.6B
| $1.26M | ﹤0.01% |
47,512
-20,090
| -30% | -$482K |
|
|
KMG
3114
DELISTED
KMG Chemicals Inc
KMG
| $1.26M | ﹤0.01% |
69,953
-116
| -0.2% | -$1.89K |
|
|
TPH
3115
DELISTED
Tri Pointe Homes
TPH
| $1.26M | ﹤0.01% |
79,901
+3,940
| +5% | +$63.7K |
|
3116
Sprott Physical Gold
PHYS
$15.9B
| $1.25M | ﹤0.01% |
113,935
-8,871
| -7% | -$94.9K |
|
|
MR
3117
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
| $1.25M | ﹤0.01% |
39,769
-342,222
| -90% | -$10.9M |
|
3118
Waterstone Financial
WSBF
$386M
| $1.25M | ﹤0.01% |
109,757
+79,652
| +265% | +$854K |
|
|
QUOT
3119
DELISTED
Quotient Technology Inc
QUOT
| $1.25M | ﹤0.01% |
+47,422
| New | +$1.06M |
|
|
ITCI
3120
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.24M | ﹤0.01% |
+73,500
| New | +$1.21M |
|
3121
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.88B
| $1.24M | ﹤0.01% |
50,003
+13,289
| +36% | +$325K |
|
|
FFNW
3122
DELISTED
First Financial Northwest, Inc
FFNW
| $1.23M | ﹤0.01% |
113,538
+200
| +0.2% | +$2.13K |
|
|
SNAK
3123
DELISTED
Inventure Foods, Inc.
SNAK
| $1.23M | ﹤0.01% |
109,441
+298
| +0.3% | +$3.76K |
|
|
SWIR
3124
DELISTED
Sierra Wireless
SWIR
| $1.23M | ﹤0.01% |
60,991
-18,828
| -24% | -$382K |
|
|
OMED
3125
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $1.23M | ﹤0.01% |
52,719
+21,937
| +71% | +$542K |
|
Similar funds
Bank of New York Mellon's Q2 2014 Portfolio in Review
As of Q2 2014, Bank of New York Mellon held 4,361 positions worth $372B, up 1.2% from $367B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bank of New York Mellon's Q2 2014 filing shows 182 new, 2,103 increased, 1,683 reduced and 213 closed positions. Its largest new stake was Navient: 6,891,839 shares worth $122M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $6.13B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q2 2014 buy was Navient: 6,891,839 shares worth $122M.
- Bank of New York Mellon added most to TJX Companies in Q2 2014, an estimated $211M increase.
- Bank of New York Mellon's biggest Q2 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.13B.
- Bank of New York Mellon fully exited Fidelity National Financial in Q2 2014, selling an estimated $240M.
- Bank of New York Mellon's ten largest holdings make up 14% of its $372B portfolio in Q2 2014.
- Bank of New York Mellon opened 182 new positions and closed 213 in Q2 2014.
- Bank of New York Mellon's portfolio value rose 1.2% quarter-over-quarter to $372B.
Based on Bank of New York Mellon's 13F filing for Q2 2014, filed 12 Aug 2014.